Saranac Partners Ltd Acquires Shares of 39,035 Danaher Corporation $DHR

Saranac Partners Ltd bought a new position in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent disclosure with the SEC. The firm bought 39,035 shares of the conglomerate’s stock, valued at approximately $7,446,000. Danaher accounts for approximately 2.2% of Saranac Partners Ltd’s investment portfolio, making the stock its 16th largest holding.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Sivia Capital Partners LLC raised its holdings in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP grew its position in shares of Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after buying an additional 14,217 shares during the period. Main Street Financial Solutions LLC increased its stake in shares of Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after acquiring an additional 886 shares in the last quarter. Ieq Capital LLC increased its stake in shares of Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after acquiring an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC lifted its position in Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after acquiring an additional 325 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on DHR shares. Piper Sandler started coverage on shares of Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. Guggenheim reduced their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Royal Bank Of Canada lifted their price objective on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. HSBC decreased their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Trading Up 0.3%

Danaher stock opened at $219.42 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market cap of $154.25 billion, a P/E ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. The firm’s 50 day moving average price is $195.80 and its 200-day moving average price is $192.40. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 EPS. On average, equities analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.